Alternatives to Canopy Immuno-Therapeutics

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Omnix Medical is developing a novel platform for advanced wound care management.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.